Cargando…
Classification of current anticancer immunotherapies
During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency for use in cancer patients, and many others are be...
Ejemplares similares
-
Trial watch: Dendritic cell-based interventions for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012) -
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer
por: Senovilla, Laura, et al.
Publicado: (2012) -
Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012) -
Trial Watch: Peptide-based anticancer vaccines
por: Pol, Jonathan, et al.
Publicado: (2015) -
Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)